# Oxytocin as Adjunctive Therapy for Schizophrenia

> **NCT01699997** · PHASE2 · COMPLETED · sponsor: **IRCCS Centro San Giovanni di Dio Fatebenefratelli** · enrollment: 32 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01699997
- **Lead sponsor:** IRCCS Centro San Giovanni di Dio Fatebenefratelli
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-04
- **Final completion:** 2015-11
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01699997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01699997, "Oxytocin as Adjunctive Therapy for Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01699997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*